The pediatrician scrolls through her notes and asks, almost in passing, whether anyone in your family has heart problems. You answer no. Then she mentions that children on the spectrum tend to carry a few extra cardiovascular risk factors, and could you keep an eye on a couple of things at home. You leave with a printout you don't fully understand, a labwork order, and a knot in your stomach.
If you're a parent of a child with autism, you may have already noticed how the medical conversation keeps expanding. Sleep, weight, lipids, medication side effects, cardiometabolic screening. None of it sounds urgent on its own. All of it adds up. This article walks through what the research actually shows about autism and heart health, where the real risks sit, and what families can pay attention to at home without spiraling.
Understanding Autism and Heart Health
Research has identified a meaningful connection between autism spectrum disorder (ASD) and cardiovascular disease, and the picture has sharpened over the last decade. Children and adults diagnosed with autism carry a higher baseline risk for several cardiometabolic conditions that, over years, can converge on heart disease[1].
The drivers are not mysterious. Children with autism are more likely to develop diabetes and dyslipidemia (abnormal blood lipids), both of which are well-established cardiovascular risk factors. Studies also report higher rates of obesity in this population, especially as children move into adolescence[1].
The following table summarizes the associated risks for individuals with autism regarding conditions linked to heart health.
| Condition | Risk Level |
| Diabetes | Increased Risk |
| Dyslipidemia | Increased Risk |
| Hypertension | No Increased Risk |
| Stroke | No Increased Risk |
| Heart Disease | Increased Risk |
Notably, individuals with autism do not appear to develop hypertension or stroke at higher rates than the general population. The risk concentrates in metabolic territory: blood sugar, lipids, body composition.
This relationship sits inside a broader cluster of conditions sometimes called cardiovascular-kidney-metabolic (CKM) syndrome, which encompasses heart disease, kidney disease, diabetes, and obesity. In our practice, the families who navigate this best are the ones who treat the pediatrician, the BCBA, and the school nurse as one extended care team rather than three separate appointments.
Careful attention to cardiometabolic health in childhood is the leverage point. Most of the heart disease research describes adult outcomes, but the conditions that lead to those outcomes (weight trajectory, lipid panels, sleep quality, activity levels) start showing up much earlier.
Risks Associated with Autism
The relationship between autism and cardiovascular and metabolic disease is an area of growing research interest. Understanding these connections helps families and clinicians spot risk early, when it's still easiest to shift.
Cardiovascular Diseases and Autism
Adults with autism are significantly more likely to develop heart disease compared to non-autistic adults. The published estimates put the risk at roughly two to three times higher for some cardiac complications[1].
A systematic review of 34 studies found that individuals with autism had a 45.9% greater associated risk of heart disease than those without autism[1]. The increased risk traces back to several converging factors: higher rates of obesity, dyslipidemia, lower physical activity, sleep disruption, and the side-effect profile of medications commonly prescribed in this population.
| Risk Factor | Autism Risk (% Increase) |
| Heart Disease | 45.9 |
| Dyslipidemia | 69.4 |
Type 1 vs. Type 2 Diabetes Risks
Children and adults with autism also show elevated diabetes risk. The overall likelihood is notably higher than in the general population, and the risk applies to both type 1 and type 2 diabetes.
A meta-analysis reported a 57.3% greater associated risk of developing diabetes overall in this population[1]. The heightened risk among children with autism is especially worth tracking, because early metabolic patterns tend to set the trajectory for adult disease.
| Type of Diabetes | Autism Risk (% Increase) |
| Overall Diabetes | 57.3 |
| Type 1 Diabetes | Data not specified |
| Type 2 Diabetes | Data not specified |
These statistics point to a clear conclusion: cardiometabolic monitoring belongs in the long-term care plan, not just the developmental one.
Impact on Cardiometabolic Health
Children with autism face unique day-to-day challenges that compound cardiometabolic risk. Restricted food preferences, sleep disturbance, medication side effects, and reduced opportunities for physical play all stack up. Setting clear, measurable behavior goals for things like mealtime routines, sleep onset, and activity windows is one of the most underused tools families have. If your child is in ABA therapy, working with the BCBA on creating behavioral goals for children with autism that include health-relevant targets can be a way to embed cardiometabolic care into the existing program rather than adding a separate to-do list.
Dyslipidemia Risk in Autistic Individuals
Research indicates that individuals with autism have a significantly higher risk of developing dyslipidemia. Specifically, the risk is roughly 69% greater compared to the general population[1]. Dyslipidemia involves abnormal cholesterol and triglyceride levels and is a major contributor to cardiovascular disease.
| Lipid Profile Indicator | General Population | Autistic Individuals |
| Triglycerides (mg/dL) | Normal: \<150 | More likely to be elevated |
| HDL Cholesterol (mg/dL) | Normal: >40 (men), >50 (women) | More likely to be lowered |
Additional research suggests that lipid abnormalities can appear from an early age in this population, which is one of the reasons pediatricians increasingly include lipid screening alongside standard well-child labs.
Obesity and Cardiovascular Disease
The correlation between autism and obesity is well documented and is a meaningful cardiovascular risk factor. Children with autism are more likely to be classified as overweight or obese, and the gap tends to widen through adolescence.
| Health Indicator | Risk in General Population | Risk in Autistic Individuals |
| Overweight/Obese (%) | \~35% | Increased risk |
| High Blood Pressure (%) | Varies by age | Increased risk |
| Diabetes (%) | \~10% | Increased risk |
The combination of dyslipidemia and obesity not only affects overall health but compounds the long-term risk for heart disease. Factors such as restricted activity, sensory-driven food preferences, and the side effects of common medications all contribute.
Factors Influencing Risks
Understanding the upstream drivers of cardiometabolic risk is what gives families something to actually act on. Two of the most actionable are sleep quality and medication management.
Sleep Quality and Cardiovascular Health
Sleep quality plays a substantial role in cardiometabolic health for children with autism, and sleep problems are common in this population. Research links poorer sleep quality to higher BMI and a higher overall count of cardiovascular risk factors among autistic adults. The same patterns appear in childhood data.
| Impact of Sleep Quality on CVD Risks |
| Factor: Poor Sleep Quality |
| Result: Higher BMI |
* *** ** ** * *** * * ** * ** *** ** ** ** *** * *** ** ** *** *** ** *** ** *** * * ** ** *** * ** ** * *** **** the role of visual timers in managing expectations, because the visual countdown removes the negotiation that typically derails sleep onset.
Medication and Diabetes Risk
Medication use, particularly second-generation antipsychotic medications, can also influence cardiometabolic outcomes in children and adults with autism. Studies have shown that adults with autism using antipsychotic medications are more likely to develop diabetes and dyslipidemia[1].
| Medication Use and Health Outcomes |
| Medication Type: Antipsychotic Medications |
These data underline why medication is a careful, ongoing conversation rather than a set-it-and-forget-it prescription. Side-effect monitoring belongs in the routine workup. For families whose children are on these medications primarily to manage challenging behavior, it's worth asking whether behavioral support could share the load. In many cases, a structured behavior plan reduces the dose needed or makes weaning possible over time. If that's something you're weighing, you can get specialized behavior support for your child and have that conversation with both a BCBA and the prescribing clinician at the same table.
Neurodevelopment and Heart Conditions
Congenital heart disease (CHD) is an important consideration when examining the relationship between autism and the heart. Recent studies suggest that individuals born with CHD have an approximately 33% increased risk of being diagnosed with autism, and the reverse relationship has also been studied.
A systematic review and meta-analysis found that children with CHD show a higher risk of social interaction and communication differences that overlap with autism characteristics. The shared developmental pathway is one of the more active areas of current research.
| Condition | Increased Risk of ASD (%) |
| Congenital Heart Disease | 33 |
Genetic Connection Between ASD and CHD
The genetic link between autism and congenital heart disease is still being mapped. Researchers are studying shared genetic variants that may predispose to both conditions, and several candidate genes have been implicated, though no single mechanism explains the overlap.
This research matters because identifying shared genetic factors could open up earlier screening and, eventually, more targeted interventions. For families whose children have both diagnoses, the practical implication today is coordination. Cardiology, developmental pediatrics, and ABA teams that talk to each other tend to catch issues earlier than ones that don't. Day-to-day in-home work, including in-home ABA therapy, gives BCBAs a direct view of activity tolerance, fatigue, and post-exertional behavior, which can be useful information to feed back to the cardiologist.
The broader picture is that children with autism may face elevated risk not just for neurodevelopmental challenges but for cardiometabolic disease across the lifespan. The leverage points (sleep, diet, activity, medication review, regular labs) are mostly the same ones that pediatricians have always recommended. The difference is that for this population, they matter sooner and they matter more.
Why Mastermind Behavior
Mastermind Behavior is a BCBA-owned in-home ABA therapy provider serving families across New Jersey, Georgia, and North Carolina. Our model is built around the BCBA who designs your child's program, the Behavior Technicians who run the daily trials in your actual rooms, and the parent training coaches who fold the work into the way your family already moves through the day. When health markers like sleep, mealtime tolerance, or activity routines are part of what's slowing your child down, those goals can sit inside the ABA program rather than alongside it. With a 90%+ staff retention rate and no onboarding waitlist, most families begin direct services within six weeks of their initial assessment, and the same team tends to stay with you long enough to actually see the trajectory shift.
If you're exploring ABA therapy and want a team that takes cardiometabolic concerns seriously alongside developmental ones, schedule a free consultation or call us at 732.507.9883. We'll listen first, then walk you through what's possible. No pressure, no commitment.
References
- Centers for Disease Control and Prevention. Data and Statistics on Autism Spectrum Disorder. https://www.cdc.gov/autism/data-research/index.html
- National Library of Medicine. Cardiovascular disease and metabolic syndrome in adults with autism spectrum disorder: A systematic review. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887535/
- National Library of Medicine. Type 1 and Type 2 Diabetes in Autism Spectrum Disorder. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023317/
